Works matching AU Mason, Warren

Results: 103
    1
    2

    ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.

    Published in:
    PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0202860
    By:
    • Yuan, Alice L.;
    • Ricks, Christian B.;
    • Bohm, Alexandra K.;
    • Lun, Xueqing;
    • Maxwell, Lori;
    • Safdar, Shahana;
    • Bukhari, Shazreh;
    • Gerber, Amanda;
    • Sayeed, Wajid;
    • Bering, Elizabeth. A.;
    • Pedersen, Haley;
    • Chan, Jennifer A.;
    • Shen, Yaoqing;
    • Marra, Marco;
    • Kaplan, David R.;
    • Mason, Warren;
    • Goodman, Lindsey D.;
    • Ezhilarasan, Ravesanker;
    • Kaufmann, Ascher B.;
    • Cabral, Matthew
    Publication type:
    Article
    3
    4

    WHY MAILER AND JONES MATTER.

    Published in:
    Mailer Review, 2012, v. 6, n. 1, p. 28
    By:
    • BEGIEBING, ROBERT J.;
    • ELLIOTT, RAY;
    • LENNON, J. MICHAEL;
    • MASON, WARREN
    Publication type:
    Article
    5

    Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.

    Published in:
    Acta Neuropathologica, 2012, v. 123, n. 6, p. 841, doi. 10.1007/s00401-011-0938-4
    By:
    • Hegi, Monika;
    • Janzer, Robert-Charles;
    • Lambiv, Wanyu;
    • Gorlia, Thierry;
    • Kouwenhoven, Mathilde;
    • Hartmann, Christian;
    • Deimling, Andreas;
    • Martinet, Danielle;
    • Besuchet Schmutz, Nathalie;
    • Diserens, Annie-Claire;
    • Hamou, Marie-France;
    • Bady, Pierre;
    • Weller, Michael;
    • den Bent, Martin;
    • Mason, Warren;
    • Mirimanoff, René-Olivier;
    • Stupp, Roger;
    • Mokhtari, Karima;
    • Wesseling, Pieter
    Publication type:
    Article
    6
    7
    8
    9

    Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma.

    Published in:
    Neuro-Oncology Practice, 2023, v. 10, n. 1, p. 89, doi. 10.1093/nop/npac068
    By:
    • Sekely, Angela;
    • Bernstein, Lori J;
    • Campbell, Kristin L;
    • Mason, Warren P;
    • Laperriere, Normand;
    • Kalidindi, Navya;
    • Or, Rosemarylin;
    • Ramos, Ronald;
    • Climans, Seth A;
    • Pond, Gregory R;
    • Millar, Barbara Ann;
    • Shultz, David;
    • Tsang, Derek S;
    • Zadeh, Gelareh;
    • Edelstein, Kim
    Publication type:
    Article
    10
    11

    Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.

    Published in:
    Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-021-01305-4
    By:
    • Jiguet-Jiglaire, Carine;
    • Boissonneau, Sebastien;
    • Denicolai, Emilie;
    • Hein, Victoria;
    • Lasseur, Romain;
    • Garcia, Josep;
    • Romain, Sylvie;
    • Appay, Romain;
    • Graillon, Thomas;
    • Mason, Warren;
    • Carpentier, Antoine F.;
    • Brandes, Alba A.;
    • Ouafik, L.'Houcine;
    • Wick, Wolfgang;
    • Baaziz, Ania;
    • Gigan, Julien P.;
    • Argüello, Rafael J.;
    • Figarella-Branger, Dominique;
    • Chinot, Olivier;
    • Tabouret, Emeline
    Publication type:
    Article
    12
    13
    14
    15

    Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae211
    By:
    • Malmström, Annika;
    • Oppong, Felix B;
    • O'Callaghan, Christopher J;
    • Wick, Wolfgang;
    • Laperriere, Normand;
    • Gorlia, Thierry;
    • Weller, Michael;
    • Henriksson, Roger;
    • Mason, Warren;
    • Platten, Michael;
    • Cantagallo, Eva;
    • Grønberg, Bjørn H;
    • Reifenberger, Guido;
    • Marosi, Christine;
    • Perry, James R
    Publication type:
    Article
    16
    17

    Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.

    Published in:
    2022
    By:
    • Song, Andrew J.;
    • Ding, Keyue;
    • Alnahhas, Iyad;
    • Laperriere, Normand J.;
    • Perry, James;
    • Mason, Warren P.;
    • Winch, Chad;
    • O'Callaghan, Chris J.;
    • Menten, Johan J.;
    • Brandes, Alba A.;
    • Phillips, Claire;
    • Fay, Michael F.;
    • Ryo Nishikawa;
    • Osoba, David;
    • Cairncross, Gregory;
    • Roa, Wilson;
    • Wick, Wolfgang;
    • Wenyin Shi
    Publication type:
    Correction Notice
    18
    19

    Management of Malignant Melanoma: Best Practices.

    Published in:
    Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. 2, p. 55, doi. 10.2310/7750.2008.08029
    By:
    • Smylie, Michael;
    • Claveau, Joël;
    • Alanen, Kenneth;
    • Taillefer, Raymond;
    • George, Ralph;
    • Wong, Ralph;
    • Mason, Warren P.
    Publication type:
    Article
    20
    21
    22

    P4‐281: QUANTIFYING CSF BIOFLUID BIOMARKERS OF NEURONAL INJURY, NEUROINFLAMMATION AND NEUROTRANSMISSION IN ANTIBODY‐MEDIATED ENCEPHALITIS.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1555, doi. 10.1016/j.jalz.2018.07.103
    By:
    • Day, Gregory S.;
    • Amtashar, Fatima;
    • Yarbrough, Melanie L.;
    • Köertvelyessy, Pèter;
    • Pruss, Harald;
    • Bucelli, Robert C.;
    • Fritzler, Marvin J.;
    • Mason, Warren;
    • Tang-Wai, David F.;
    • Steriade, Claude;
    • Hébert, Julien;
    • Herries, Elizabeth M.;
    • Ladenson, Jack H.;
    • Morris, John C.;
    • Fagan, Anne M.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 159, n. 3, p. 509, doi. 10.1007/s11060-022-04088-3
    By:
    • Hagiwara, Akifumi;
    • Schlossman, Jacob;
    • Shabani, Soroush;
    • Raymond, Catalina;
    • Tatekawa, Hiroyuki;
    • Abrey, Lauren E.;
    • Garcia, Josep;
    • Chinot, Olivier;
    • Saran, Frank;
    • Nishikawa, Ryo;
    • Henriksson, Roger;
    • Mason, Warren P.;
    • Wick, Wolfgang;
    • Cloughesy, Timothy F.;
    • Ellingson, Benjamin M.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Emerging Biomarkers in Glioblastoma.

    Published in:
    Cancers, 2013, v. 5, n. 3, p. 1103, doi. 10.3390/cancers5031103
    By:
    • McNamara, Mairéad G.;
    • Sahebjam, Solmaz;
    • Mason, Warren P.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.

    Published in:
    Oncologist, 2019, v. 24, n. 4, p. 521, doi. 10.1634/theoncologist.2018-0290
    By:
    • Brandes, Alba A.;
    • Gil‐Gil, Miguel;
    • Saran, Frank;
    • Carpentier, Antoine F.;
    • Nowak, Anna K.;
    • Mason, Warren;
    • Zagonel, Vittorina;
    • Dubois, François;
    • Finocchiaro, Gaetano;
    • Fountzilas, George;
    • Cernea, Dana Michaela;
    • Chinot, Oliver;
    • Anghel, Rodica;
    • Ghiringhelli, Francois;
    • Beauchesne, Patrick;
    • Lombardi, Giuseppe;
    • Franceschi, Enrico;
    • Makrutzki, Martina;
    • Mpofu, Chiedzo;
    • Urban, Hans‐Joerg
    Publication type:
    Article